I n 1997, the Jour nal fea tured 6 re views cov er ing the rap idly evolv ing world of schizo phre nia re search (1) (2) (3) (4) (5) (6) . The writ ers were global lead ers in their re spec tive fields. Heinz Leh mann (Cana da's pre emi nent psy cho phar ma colo gist, who has un fortu nately died since that re view was pub lished) and Tom Ban out lined the his tory of psy cho phar ma col ogy in a suc cinct and read able fash ion (5) . Noted Na tional In sti tute of Men tal Health clini cal sci en tist Carol Tam minga re viewed what was known in 1997 of the new mira cle drugs, the "atypi cal" an tipsy chot ics (6) . Bob Bil der, a neu rop sy cholo gist from Hill side Hos pi tal, New York, pro vided Ca na dian Jour nal of Psy chia try read ers with a thor ough un der stand ing of the cog ni tive di men sions of schizo phre nia-at least in terms of what was known about this rap idly chang ing area in 1997 (2) . Heinz Häf ner and Wolf ram an der Hei den from Mann heim, Ger many, com pre hen sively re viewed schizo phre nia epi de mi ol ogy (4), and Larry Davidson and Tom McGlashan from Yale con trib uted a metaana lysis of out come stud ies (3) . Nancy An dreasen, edi tor of the Ameri can Jour nal of Psy chia try, sum ma rized what was then a new topic-the po ten tial role of the thala mus in schizo phre nia pa tho physi ol ogy (1).
In 2001, 4 years later, much that was new is be ing dis puted, as is only right in sci ence. Sci en tific ad vance thrives on sup po sition, ex peri men ta tion, er ror, re in ter pre ta tion, crea tive leaps, and fail ures to rep li cate. Oc ca sion ally, out of the dis putes, new un der stand ings arise that stand up to the test of time. And out of these new un der stand ings, new thera pies evolve that alle vi ate symp toms (that is the best that can be said for most psy chi at ric treat ments) and some times eradi cate them (phobic de sen si ti za tion is an ex am ple). Once in a very long time, the new treat ments re turn suf fer ers to their pre mor bid state (an ti de pres sants do this in some in stances) and, very rarely, they pre vent dis ease al to gether (fam ily in ter ven tion in child psy chia try is a case in point). Some psy chi at ric thera pies even claim to im prove on the pre mor bid state (psy cho analy sis and other forms of psy cho ther apy have made such as ser tions). For schizo phre nia, be cause the ill ness it self is so se vere, we are at pres ent con tent to be able to al le vi ate symp toms with out in duc ing treat ment ef fects that are harder to bear than the illness it self. The his tory of schizo phre nia treat ment is un for tunately re plete with thera peu tic claims for in ter ven tions that height ened rather than abated the pa ti ent's suf fer ing, augmented rather than re duced the stigma as so ci ated with this illness, con tracted rather than ex panded the pa ti ent's abili ties and qual ity of life, and mag ni fied rather than less ened the burden borne by fam ily mem bers.
In this is sue, Ca na dian and Ameri can ex perts ex am ine 2 current treat ments and dis sect them to see how they work. Pro fessor Philip See man has de voted his pro fes sional life to try ing to un der stand the way an tipsy chotic medi ca tions do what they do in the brain (in the hope of one day be ing able to work back to dis cover the im pair ment that causes schizo phre nia in the first place). Since the atypi cal an tipsy chot ics de scribed by Dr Tamminga (6) in 1997 do the job more ef fec tively and with fewer side ef fects than the older drugs, Dr See man care fully as sesses what makes them "atypi cal." What is it that con fers atypi cal ity and how is that an im prove ment over "typi cal ity" when it comes to an tipsy chotic ef fec tive ness? He ele gantly ex plains the "fast-off" hy pothe sis of atypi cal ac tion and then out lines how this hy pothe sis ac counts for eve ry day clini cal phe nom ena.
Dr Neil Rec tor, whose in ter est in schizo phre nia pre dates his cur rent in ter na tion ally ac knowl edged ex per tise in cognitivebehavioural ther apy, re views with Pro fes sor Aaron Beck, the fa ther of cog ni tive ther apy, the mecha nisms and out comes of this mode of treat ment for symp toms of schizo phre nia. The work ex tends Beck's cog ni tive treat ment of de pres sion and the early suc cesses of cog ni tive ther apy for schizo phre nia, as prac tised in the UK. The authors show how tar geted ther apy can help at tenu ate prob lem atic bi ases in the think ing of patients; that is, neu tral ize seem ingly mo men tous oc cur rences, teach own er ship of in ter nal sen sa tions, and lessen the enormity of the threat per ceived in mun dane events.
Un der stand ing cog ni tive ther apy and the ju di cious and timely use of ap pro pri ate psy cho phar ma ceu ti cals will sub stan tially in crease psy chi at ric ef fec tive ness in treat ing schizo phre nia.
